Table 5 Comparison of G1-2 adverse events between TRT and non-TRT group
Adverse Events | TRT Group (n = 99) | non-TRT Group (n = 98) | P value |
|---|---|---|---|
Any Grades | 82 (82.8%) | 82 (83.7%) | 0.874 |
G1-2 Totally | 78 (78.8%) | 78 (79.6%) | 0.889 |
Leucopenia /White-cell count decreased | 44 (44.4%) | 34 (34.7%) | 0.190 |
Neutropenia /Neutrophil count decreased | 23 (23.2%) | 21 (21.4%) | 0.864 |
Thrombocytopenia /Platelet count decreased | 7 (7.1%) | 2 (2.0%) | 0.170 |
Anaemia | 5 (5.1%) | 13 (13.3%) | 0.051 |
Nausea | 27 (27.3%) | 25 (25.5%) | 0.872 |
Decreased appetite | 17 (17.2%) | 28 (28.6%) | 0.063 |
Constipation | 9 (9.1%) | 14 (14.3%) | 0.276 |
Diarrhea | 6 (6.1%) | 7 (7.1%) | 0.783 |
Radiation esophagitis | 38 (38.4%) | / | / |
Pneumonitis | 16 (16.2%) | 9 (9.2%) | 0.199 |
Myocarditis | 0 (0%) | 0 (0%) | / |
Hypothyroid | 1 (1.0%) | 1 (1.0%) | 1.000 |
Atrial fibrillation | 0 (0%) | 0 (0%) | / |